Hospitalized players step up focus on cancer care amid surge in cases news


Amid rising cases of cancer, Indian hospitals are promoting cancer care services. Rajiv Gandhi Cancer Institute, Aster DM Healthcare, Fortis Healthcare and Yatharth Hospital are set to expand bed capacity in the next two to three years to meet the growing demand for advanced cancer treatment.

Apollo Hospitals' “Health of the Nation 2024” report released on April 3 revealed a worrying trend: cancer cases are rising rapidly in India. Projections indicate that cases will increase from 1.39 million in 2020 to 1.57 million by 2025, an increase of 13 percent in just five years. According to Apollo findings, the burden of cancer measured in disability-adjusted life years (DALYs) is expected to increase from 27 million in 2021 to about 30 million by 2025, earning India the title of “Cancer Capital”.

Delhi's Rajiv Gandhi Cancer Institute and Research Center (RGCIRC), in collaboration with ABC, plans to expand its Niti Bagh Center daycare facility and add 155 beds over the next three years. Additionally, it has launched several awareness programs emphasizing cancer prevention and early detection. Expanding its reach, the institute conducts bi-weekly continuing medical education sessions in Tier-II cities, thereby expanding access to vital health care resources.

“Apart from conducting awareness camps, we also conduct frequent screening camps in collaboration with NGOs. We have increased our reach to underprivileged areas to raise awareness and provide assistance. Nearly 1,30,000 people have been screened so far, out of which 7,000 were found to have pre-cancer and 690 were in the early stages of cancer. RGCIRC Chief Executive Officer DS Negi said, patients suffering from cancer in the camps are treated free of cost by the institute.

Fortis Healthcare in Bengaluru recorded a significant growth of 50 per cent in cancer cases in 2022, continuing the trend of 20 per cent year-on-year growth in oncology care seen in 2023-24. Fortis Cancer Institute provides comprehensive cancer care in Tier-I cities and plans to expand services to Tier-II cities, thereby increasing access to specialized care for underserved populations.

“Fortis has made a significant investment of over Rs 450 crore in cancer care, setting up top-class facilities and acquiring state-of-the-art technology. Anil Vinayak, Group Chief Operating Officer, Fortis Healthcare, said, “Our ongoing investment strategy is focused on further enhancing our oncology services and infrastructure to meet the growing demand for specialized cancer care.

Fortis Cancer Institute offers state-of-the-art technology in cancer care, including Asia Pacific's first Gamma Knife ESPRIT and North India's first MR Linac. These advancements facilitate precise, minimally invasive tumor treatment, underscoring the institute's commitment to cutting-edge treatment modalities.

“With our focus on hematological conditions, we have established the Fortis Institute of Blood Disorders, which specializes in the treatment of blood cancers and disorders, and we have one of the largest and most complex bone marrow transplant units in the country . We are also offering NexCAR19, a market-authorized CAR-T cell therapy developed in collaboration with ImmunoACT,” Vinayak said.

“We estimate that oncology will contribute 20-25 per cent to our total business by FY2025, with expected revenues of around Rs 1,400 crore. “This growth will be driven by our continued focus on expanding and enhancing our cancer care capabilities across India,” Vinayak said.

Aster DM Healthcare's domestic operations provide comprehensive cancer care services, including surgical, medical and radiation oncology as well as advanced diagnostic and treatment modalities such as digital mammography, robotic surgery, PET-CT and brachytherapy. They also provide specialized support services such as pain management, palliative care and interventional radiology.

Aster DM has outlined ambitious growth plans, with a target of adding 1,700 beds by FY27. Their expansion strategy includes a mix of brownfield and greenfield projects with an allocated capital of around Rs 1,000 crore. Additionally, the company continues to keep an eye on inorganic expansion opportunities during this period, demonstrating a comprehensive approach to continued growth.

“Expansion in India will include the upcoming 454-bed Aster Capital in Trivandrum and 264-bed Aster MIMS Kasaragod by FY2027. The company will then look to add bed capacity of about 100 beds to the existing hospitals at Aster Medcity and Aster MIMS Kannur and 159 beds at Aster Whitefield. “The expansion will take the company's total bed strength in India to more than 6,600 beds,” said Nitish Shetty, CEO, Aster DM Healthcare, India.

Additionally, Aster DM expressed interest in expanding into promising markets such as Maharashtra, Uttar Pradesh and other Tier-II and Tier-III cities. With 70 per cent of its business thriving in Tier-I, Tier-II and Tier-III cities, Aster is set to introduce the regional model in additional locations, providing sustainable healthcare solutions.

“We are projecting a growth of 15 percent per year. We plan to further expand our presence, both inorganic and organic, with a focus on dominating the market. However, until we get clarity on our strategy, we refrain from experimental moves,'' Shetty said.

Yathar Hospital in Noida is advancing cancer care with cutting-edge treatments such as advanced linear accelerators (for example, Versa-HD with VMAT) and brachytherapy (for example, Flexitron with QA and mold room technology). Additionally, they provide minimally invasive and robotic oncosurgical procedures. In diagnosis, the group provides whole body PET-CT scan, X-ray, ultrasound, CT scan, MRI imaging, mammography and routine lab services, including immunohistochemistry (IHC), fluorescence in situ hybridization (FISH) techniques and frozen Are. Section.

Yatharth has acquired land adjacent to its Greater Noida and Noida Extension hospitals. The move aims to increase the bed capacity from 400 to 600 in Greater Noida and from 450 to 700 in Noida Extension. Additionally, the hospital is considering brownfield expansion efforts as well as a greenfield project for an additional 300 beds.

“Apart from organic expansion, we are continuously evaluating inorganic opportunities and strategic partnerships and are committed to expanding our bed capacity in the coming years. Our commitment is to complete one transaction every year till FY26. For further inorganic expansion, we are looking at the regions of Delhi NCR, Haryana, Uttar Pradesh, Madhya Pradesh and are open to both O&M (operations and maintenance) model as well as equity purchase,” said Yathar Group. Director Yatharth Tyagi said. hospital.

Leave a Comment

“The Untold Story: Yung Miami’s Response to Jimmy Butler’s Advances During an NBA Playoff Game” “Unveiling the Secrets: 15 Astonishing Facts About the PGA Championship”